Transcatheter arterial chemoembolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma (Q33998674)

30 July 2017

Transcatheter arterial chemoembolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma (English)

1 reference

30 July 2017

1 reference

Kazuhiro Kasai

1

1 reference

30 July 2017

Akira Ushio

2

1 reference

30 July 2017

Kei Sawara

3

1 reference

30 July 2017

Yasuhiro Miyamoto

4

1 reference

30 July 2017

Yukiho Kasai

5

1 reference

30 July 2017

Kanta Oikawa

6

1 reference

30 July 2017

Hidekatsu Kuroda

7

1 reference

30 July 2017

Yasuhiro Takikawa

8

1 reference

30 July 2017

Kazuyuki Suzuki

9

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

World Journal of Gastroenterology

30 July 2017

1 reference

30 July 2017

16

1 reference

30 July 2017

27

1 reference

30 July 2017

3437-3444

1 reference

Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Immunohistochemical study of expression and cellular localization of the multidrug resistance gene product P-glycoprotein in primary liver carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Toxicity and response criteria of the Eastern Cooperative Oncology Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Surgery and portal hypertension

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Combined peripheral and central chemoembolization of liver tumors. Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Clinicopathological study on combination therapy consisting of arterial infusion of lipiodol-dissolved SMANCS and transcatheter arterial embolization for hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Experimental animal models of adriamycin cardiotoxicity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Trends in mortality from primary liver cancer in Europe

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904893

Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil

29 October 2018

1 reference

12 December 2020

A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma

1 reference

12 December 2020

Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer

1 reference

12 December 2020

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

Transarterial chemoembolization using cisplatin powder in a rabbit model of liver cancer

1 reference

12 December 2020

[Antitumor activity of cis-dichlorodiammineplatinum(II) and its effect on cell cycle progression]

1 reference

12 December 2020

Intraarterial infusion chemotherapy with lipiodol-CDDP suspension for hepatocellular carcinoma.

1 reference

12 December 2020

Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors

1 reference

12 December 2020

Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma

1 reference

12 December 2020

Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma

1 reference

12 December 2020

Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion

1 reference

12 December 2020

Subacute cardiotoxicity of adriamycin in the rat: biochemical and ultrastructural investigations

1 reference

12 December 2020

Hepatic artery embolization in 120 patients with unresectable hepatoma

1 reference

12 December 2020

Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer

1 reference

12 December 2020

Transcatheter arterial embolization (TAE) in treatment for hepatoma--analysis of three-year survivors

1 reference

12 December 2020

Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents

1 reference

12 December 2020

[TNM classification of malignant tumors: the new 1987 edition]

1 reference

12 December 2020

Changing incidence of hepatocellular carcinoma in Japan

1 reference

12 December 2020

Treatment of lung cancer with bronchial artery infusion of cisplatin and intravenous sodium thiosulfate rescue

1 reference

12 December 2020

Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and risk factors

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V16.I27.3437

1 reference

30 July 2017

1 reference

30 July 2017

1 reference